Live feed
Filing
SC 13G
SC 13G0001615774-18-006903·Crinetics Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
CRINETICS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 22663K107
Event date: 2018-07-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,443,101
- Percent of class
- 14.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001615774-18-006903
- Form type
- SC 13G
- Filer
- Crinetics Pharmaceuticals, Inc.
- CIK
- CIK 1658247
- Filed
- Jul 26, 2018
- Reporting period
- Jul 20, 2018
- Description
- Schedule 13G beneficial ownership